Fulvestrant – a new treatment for postmenopausal women with hormone-sensitive advanced breast cancer

Author： Possinger Kurt  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.12, 2004-12, pp. : 2549-2558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fulvestrant: A Review of its Use in the Management of Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women

By Croxtall Jamie D.   McKeage Kate  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 363-380

Adis International

Access to resources Recommend Favorite

Fulvestrant: A Review of its Use in Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women with Disease Progression following Antiestrogen Therapy

By McKeage K.   Curran M.P.   Plosker G.L.  

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 633-648

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK

By Nuijten M.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 379-397

Adis International

Access to resources Recommend Favorite

Letrozole: A Review of its Use in the Treatment of Postmenopausal Women with Hormone-Responsive Early Breast Cancer

By Keating Gillian M.  

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1681-1705

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Profile of Intramuscular Fulvestrant in Advanced Breast Cancer

By Robertson J.F.R.  

Clinical Pharmacokinetics, Vol. 43, Iss. 8, 2004-01 ,pp. : 529-538

Adis International

Access to resources Recommend Favorite